NCBIO, the North Carolina Biosciences Organization
NCBIO is the trade association for North Carolina’s life science industry. Members include companies and research institutions working in the pharmaceutical, medical device, diagnostic, clinical research and agricultural biotechnology sectors, as well as firms and nonprofits that provide support services to life science companies. Founded in 1994, NCBIO works to help North Carolina’s life sciences community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life through effective advocacy and policy.
Member Benefits
A variety of discount programs are available to members.
Partners and Resources
NCBIO works with national organizations and connects with many North Carolina life science resources.
BIO: CMS decision enormous setback for Alzheimer’s patients, dangerous infringement on FDA autonomy
On April 7, the Centers for Medicare and Medicaid Services held to its original decision to limit coverage of the…
Read MoreBiotech joins efforts to aid in humanitarian relief in Ukraine
The biotech and life sciences industry is coming together to donate a range of critical medical supplies, equipment, and medications…
Read MoreCMS decision not to cover Alzheimer’s treatment a bad one
NCBIO stands in solidarity with patient advocates and industry leaders in opposing the Centers for Medicare and Medicaid Services’ draft…
Read MoreWho pays to create new medicines?
Does government spending on drug development justify government price controls on medicines? Not when the private sector spends $102 billion on clinical R&D and the NIH spends less than $3 billion.
Read More
2022 Legislative Reception (photo gallery)
NCBIO held its 2022 Legislative Reception on Wednesday, June 22, at the North Carolina Museum of History in Raleigh. The event was well attended by NCBIO members who were joined by a number of state senators, including Life Science Caucus Co-Chair Sen. Mike Woodard and Sens. Lisa Barnes, Sydney Batch, Steve Jarvis and Joyce Waddell.
Read More
Supply chain during pandemic discussed at June Biomanufacturers Forum meeting
Representatives of Merck and NCBIO discussed the supply-chain difficulties and issues the COVID-19 pandemic created for the bioscience industry at the quarterly NCBIO Biomanufacturers Forum meeting held Wednesday, June 1, at the NC Biotechnology Center.
Read More
Medical Device Forum discusses current FDA regulatory environment
NCBIO members got an overview of the Food and Drug Administration’s regulatory environment for medical devices both during the pandemic and now at the NCBIO Medical Device Forum held May 11 at the NC Biotechnology Center.
Read More
Lead gifts from Alexandria Real Estate, Biogen, Hatteras push Taylor scholarship fund past $200,000
The Samuel M. Taylor Memorial Scholarship Fund created by NCBIO at the North Carolina Community Colleges Foundation Inc. has exceeded $200,000 in gifts and pledges with leadership gifts coming from Alexandria Real Estate Equities, Biogen and Hatteras Venture Partners.
Read MoreSustaining Members
Supporting Members
